- Home
- NKTR vs SMTI Comparison
NKTR vs SMTI Comparison
Compare NKTR & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- SMTI
- Stock Information
- Founded
- NKTR 1990
- SMTI 1982
- Country
- NKTR United States
- SMTI United States
- Employees
- NKTR N/A
- SMTI N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- SMTI Medical/Dental Instruments
- Sector
- NKTR Health Care
- SMTI Health Care
- Exchange
- NKTR Nasdaq
- SMTI Nasdaq
- Market Cap
- NKTR 247.9M
- SMTI 288.2M
- IPO Year
- NKTR 1994
- SMTI N/A
- Fundamental
- Price
- NKTR $0.93
- SMTI $33.01
- Analyst Decision
- NKTR Buy
- SMTI Buy
- Analyst Count
- NKTR 3
- SMTI 1
- Target Price
- NKTR $4.00
- SMTI $44.00
- AVG Volume (30 Days)
- NKTR 2.2M
- SMTI 36.2K
- Earning Date
- NKTR 11-07-2024
- SMTI 11-12-2024
- Dividend Yield
- NKTR N/A
- SMTI N/A
- EPS Growth
- NKTR N/A
- SMTI N/A
- EPS
- NKTR N/A
- SMTI N/A
- Revenue
- NKTR $93,137,000.00
- SMTI $78,056,873.00
- Revenue This Year
- NKTR $12.85
- SMTI $29.95
- Revenue Next Year
- NKTR N/A
- SMTI $19.68
- P/E Ratio
- NKTR N/A
- SMTI N/A
- Revenue Growth
- NKTR 5.53
- SMTI 24.66
- 52 Week Low
- NKTR $0.47
- SMTI $26.00
- 52 Week High
- NKTR $1.93
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- NKTR 33.04
- SMTI 34.95
- Support Level
- NKTR $0.89
- SMTI $31.13
- Resistance Level
- NKTR $1.04
- SMTI $34.22
- Average True Range (ATR)
- NKTR 0.07
- SMTI 1.80
- MACD
- NKTR -0.00
- SMTI -0.63
- Stochastic Oscillator
- NKTR 14.81
- SMTI 12.98
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.